文献速递免疫规划传染病防控与疫情报告

2017-2018年流感季节美国国防部人员接种流感疫苗与呼吸道病毒干扰现象

Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season.
PubMed 文献 · Vaccine · 2019-10-10

本研究以2017-2018年流感季节美国国防部人员为对象,采用检测阴性设计,比较接种与未接种流感疫苗者的呼吸道病毒检出情况。结果显示,接种流感疫苗与病毒干扰无显著关联(非流感病毒调整OR 0.97,95%CI 0.86-1.09,P=0.60)。但按病毒种类分析结果不一:接种与冠状病毒和人偏肺病毒检出显著相关,同时对多数流感病毒、副流感病毒、呼吸道合胞病毒及非流感病毒合并感染显示显著保护。

要点

  • 接种流感疫苗与总体病毒干扰无显著关联(调整OR 0.97,95%CI 0.86-1.09)。
  • 接种与冠状病毒和人偏肺病毒检出显著相关。
  • 接种对多数流感病毒、副流感病毒、呼吸道合胞病毒及非流感病毒合并感染有显著保护。

核心结论

  • 接种流感疫苗与病毒干扰无显著关联(调整OR 0.97,95%CI 0.86-1.09,P=0.60)。
  • 按病毒种类分析结果不一:接种与冠状病毒和人偏肺病毒检出显著相关,对多数流感病毒、副流感病毒、呼吸道合胞病毒及非流感病毒合并感染显示显著保护。

研究设计与样本

  • 检测阴性设计,比较2017-2018年流感季节美国国防部人员接种与未接种流感疫苗者的呼吸道病毒检出情况。
  • 非流感呼吸道病毒感染者2880人,全阴性对照3240人;流感病例3349例,对照包括全部对照(N=6120)、非流感阳性对照(N=2880)和全阴性对照(N=3240)。

主要发现

  • 接种与未接种者相比,非流感病毒的调整OR为0.97(95%CI 0.86-1.09,P=0.60)。
  • 流感病例与三种对照比较的调整OR范围0.46-0.51。
  • 接种与冠状病毒和人偏肺病毒检出显著相关。
  • 接种对多数流感病毒、副流感病毒、呼吸道合胞病毒及非流感病毒合并感染显示显著保护。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Receiving influenza vaccination may increase the risk of other respiratory viruses, a phenomenon known as virus interference. Test-negative study designs are often utilized to calculate influenza vaccine effectiveness. The virus interference phenomenon goes against the basic assumption of the test-negative vaccine effectiveness study that vaccination does not change the risk of infection with other respiratory illness, thus potentially biasing vaccine effectiveness results in the positive direction. This study aimed to investigate virus interference by comparing respiratory virus status among Department of Defense personnel based on their influenza vaccination status. Furthermore, individual respiratory viruses and their association with influenza vaccination were examined. RESULTS: We compared vaccination status of 2880 people with non-influenza respiratory viruses to 3240 people with pan-negative results. Comparing vaccinated to non-vaccinated patients, the adjusted odds ratio for non-flu viruses was 0.97 (95% confidence interval (CI): 0.86, 1.09; p = 0.60). Additionally, the vaccination status of 3349 cases of influenza were compared to three different control groups: all controls (N = 6120), non-influenza positive controls (N = 2880), and pan-negative controls (N = 3240). The adjusted ORs for the comparisons among the three control groups did not vary much (range: 0.46-0.51). CONCLUSIONS: Receipt of influenza vaccination was not associated with virus interference among our population. Examining virus interference by specific respiratory viruses showed mixed results. Vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus; however, significant protection with vaccination was associated not only with most influenza viruses, but also parainfluenza, RSV, and non-influenza virus coinfections.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wolff GG. Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017-2018 influenza season. Vaccine. 2019. PMID: 31607599. doi:10.1016/j.vaccine.2019.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。